Tony Sycamore, Market Analyst, IG updated his technical views on the Nasdaq, the ASX200, and crude oil (WTI)
Amplia Therapeutics is in pursuit of a cancer drug for pancreatic cancer and possibly other indications including ovarian cancer, the New Criterion’s Tim Boreham reports
The Australian market couldn’t sustain the early May rally, weighed down by a surprisingly high April CPI reading and some negative earnings updates
RBC Capital Markets sees further market share gains ahead for specialist wealth management platforms Netwealth, Hub24 and Praemium
Michael Gable of Fairmont Equities reports shares in goldminer Resolute Mining have broken out to the upside
With the Big Four banks regarded as overvalued, investors are pondering whether there’s better value in their smaller counterparts that trade on more modest valuations but with similar or higher dividend yields
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Sims
The Chartist reports it looks like CSL shares might be ready to leave the past four-year pause in the past
Lendlease plans to divest of offshore assets and bring its focus back to Australia, resulting in reduced gearing and capital returns. Brokers are positive, but warn of the risks involved
